Valuation (36%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 50.51 | N/A |
PEG Ratio (TTM) | -3.66 | N/A |
P/S Ratio (TTM) | 12.70 | N/A |
P/B Ratio (TTM) | 0.92 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | 20.57 | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.66% | N/A |
ROE (TTM) | 1.91% | N/A |
Net Profit Margin (TTM) | 25.14% | N/A |
ROIC 5YR AVG | 5.58% | N/A |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 15.52% | 1,346.98% | 803.98% |
Revenue | -9.91% | 1,400.07% | 833.93% |
Net Income | -9.50% | 1,332.11% | 788.51% |
Cash Flow | N/A | N/A | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.52 | N/A |
Quick Ratio (TTM) | 0.52 | N/A |
D/E Ratio (TTM) | 0.06 | N/A |
Interest Coverage (TTM) | -33.96 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 5.69 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | -2.16% | N/A |